Loading clinical trials...
Loading clinical trials...
This is a phase 2, single-center prospective, double-blind, placebo-controlled, crossover study in Type 1 diabetes and celiac disease subjects attempting a GFD for at least one year prior to screening...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Entero Therapeutics
Collaborators
NCT07362654 · Celiac Disease, Gluten Sensitivity, and more
NCT07239336 · Celiac Disease
NCT07039773 · Celiac Disease
NCT06356220 · Celiac Disease in Children, Nutrition Disorder, Child
NCT07069127 · Celiac Disease, Dentin Hypersensitivity, and more
Stanford University
Palo Alto, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions